Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 138.64%55.22B | -186.13%-14.79B | 24.90%29B | 163.14%9.85B | 1,996.17%31.15B | -11.27%23.14B | 254.34%17.17B | 156.96%23.22B | -251.40%-15.6B | -109.20%-1.64B |
| Net income from continuing operations | 25.42%20.37B | 28.71%5.43B | 20.69%5.41B | 11.14%4.39B | 43.24%5.13B | 11.14%16.24B | 7.18%4.22B | 16.22%4.49B | 7.34%3.95B | 14.33%3.58B |
| Operating gains losses | -64.00%-205M | -12.50%-27M | -168.25%-43M | 21.79%-61M | 13.95%-74M | -95.31%-125M | -110.81%-24M | 176.83%63M | 36.07%-78M | -4.88%-86M |
| Depreciation and amortization | 3.29%3.08B | -7.80%757M | 0.66%768M | 7.88%780M | 14.84%774M | 4.45%2.98B | 9.32%821M | 7.92%763M | 2.12%723M | -2.03%674M |
| Provision for loans, leases and other losses | 34.96%4.36B | 19.88%1.01B | 33.69%881M | 54.78%1.42B | 29.15%1.05B | 30.96%3.23B | 16.67%840M | 6.98%659M | 53.33%920M | 52.82%813M |
| Deferred tax | 85.87%-216M | -212.12%-111M | 116.37%127M | -5.69%-260M | 104.62%28M | -50.20%-1.53B | 111.97%99M | -567.47%-776M | -156.25%-246M | -132.18%-606M |
| Change in working capital | 1,089.36%27.83B | -294.91%-21.85B | 21.24%21.85B | 117.14%3.58B | 502.74%24.25B | -67.62%2.34B | 170.37%11.21B | 378.22%18.02B | -477.02%-20.87B | -143.47%-6.02B |
| -Change in loans | 63.49%-36.78B | -3.62%-35.65B | 121.58%2.22B | 58.86%-17.19B | 197.01%13.84B | -2,466.83%-100.76B | -249.81%-34.4B | -139.13%-10.29B | -212.00%-41.79B | -1,306.94%-14.27B |
| -Change in other working capital | -37.33%64.61B | -69.73%13.81B | -30.67%19.63B | -0.71%20.77B | 26.18%10.41B | 3,371.25%103.1B | 848.72%45.61B | 225.65%28.32B | 10.51%20.92B | -34.90%8.25B |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | 138.64%55.22B | -186.13%-14.79B | 24.90%29B | 163.14%9.85B | 1,996.17%31.15B | -11.27%23.14B | 254.34%17.17B | 156.96%23.22B | -251.40%-15.6B | -109.20%-1.64B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -228.29%-68.57B | 233.81%17.42B | -37.05%-37.97B | -658.47%-31.91B | -214.05%-16.11B | 26.10%-20.89B | -1,105.65%-13.02B | -25.40%-27.71B | 3.78%5.71B | 233.30%14.13B |
| Proceeds payment in interest bearing deposits in bank | 209.04%15.66B | 360.83%22.46B | 63.83%-6.85B | -179.78%-18.05B | 80.85%18.1B | -72.97%5.07B | -151.99%-8.61B | -228.42%-18.95B | 94.76%22.62B | 372.94%10.01B |
| Net PPE purchase and sale | 1.62%-2.24B | 18.18%-549M | 26.08%-530M | -17.80%-483M | -41.29%-681M | 16.48%-2.28B | 12.74%-671M | -28.73%-717M | 41.93%-410M | 30.95%-482M |
| Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | -841.88%-12.7B | --0 | -99.71%5M | ---12.72B | --9M |
| Net investment purchase and sale | -647.19%-81.98B | -20.03%-4.49B | -280.25%-30.59B | -253.83%-13.38B | -829.92%-33.53B | 76.14%-10.97B | 77.84%-3.74B | 53.98%-8.04B | 30.00%-3.78B | 173.69%4.59B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -228.29%-68.57B | 233.81%17.42B | -37.05%-37.97B | -658.47%-31.91B | -214.05%-16.11B | 26.10%-20.89B | -1,105.65%-13.02B | -25.40%-27.71B | 3.78%5.71B | 233.30%14.13B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 17.62%-6.71B | 77.48%-661M | -34.34%-3.9B | 60.90%-915M | -3,617.14%-1.23B | 17.16%-8.15B | 52.60%-2.94B | 32.02%-2.91B | 28.33%-2.34B | -99.10%35M |
| Net issuance payments of debt | 166.52%2.26B | 644.25%2.51B | -148.44%-2B | 175.61%1.9B | -140.53%-154M | 23.36%-3.39B | 90.56%-461M | 73.54%-803M | -10.43%-2.51B | -93.41%380M |
| Net commonstock issuance | -1,403.35%-2.72B | -788.73%-978M | -349.72%-796M | -928.17%-588M | -309.25%-362M | 27.44%209M | 273.17%142M | -4,325.00%-177M | -73.51%71M | 1,061.11%173M |
| Net preferred stock issuance | 54.37%2.6B | 122.20%111M | 1,043.75%1.1B | --0 | 91.70%1.39B | --1.68B | ---500M | --96M | --1.36B | --723M |
| Cash dividends paid | -32.59%-8.8B | -8.27%-2.29B | -8.86%-2.2B | -75.12%-2.21B | -69.44%-2.1B | -19.61%-6.64B | -73.08%-2.12B | -63.70%-2.02B | -0.80%-1.26B | 32.65%-1.24B |
| Net other financing activities | -550.00%-39M | -1,200.00%-13M | -500.00%-12M | -600.00%-14M | ---- | 71.43%-6M | 66.67%-1M | 0.00%-2M | 77.78%-2M | 85.71%-1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 17.62%-6.71B | 77.48%-661M | -34.34%-3.9B | 60.90%-915M | -3,617.14%-1.23B | 17.16%-8.15B | 52.60%-2.94B | 32.02%-2.91B | 28.33%-2.34B | -99.10%35M |
| Net cash flow | ||||||||||
| Beginning cash position | -8.50%56.72B | -36.76%34.93B | -20.78%48.62B | -4.23%71.2B | -8.50%56.72B | -14.38%61.99B | -31.27%55.23B | -38.13%61.37B | -13.83%74.35B | -14.38%61.99B |
| Current changes in cash | -240.35%-20.06B | 63.39%1.98B | -74.15%-12.88B | -87.87%-22.98B | 10.35%13.81B | 50.96%-5.89B | 106.58%1.21B | 57.35%-7.39B | -197.47%-12.23B | 12.16%12.52B |
| Effect of exchange rate changes | -42.52%361M | -57.60%120M | -165.52%-819M | 153.15%396M | 515.00%664M | -61.02%628M | 1,032.00%283M | 182.89%1.25B | -298.67%-745M | -105.88%-160M |
| End cash position | -34.73%37.02B | -34.73%37.02B | -36.76%34.93B | -20.78%48.62B | -4.23%71.2B | -8.50%56.72B | -8.50%56.72B | -31.27%55.23B | -38.13%61.37B | -13.83%74.35B |
| Free cash from | 153.98%52.98B | -192.96%-15.33B | 26.52%28.47B | 158.50%9.37B | 1,534.02%30.47B | -10.66%20.86B | 238.72%16.5B | 165.39%22.5B | -266.80%-16.01B | -112.38%-2.13B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.